RA Denosumab on Bone Microstructure Study

NCT01770106 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Denosumab
DRUG: Alendronate

Sponsor

Chinese University of Hong Kong